The blood industry plays a vital role in supporting the development of advanced therapies
Category: News
Cell and gene therapies are often delayed by technical and regulatory issues
New consultancy aims to deliver personalised senior expertise in healthcare communications
Results show disease control and tumour shrinkage with GNS561 and MEK inhibitor combination
Trial shows GRI-0621 improved lung function with signs of fibrosis resolution
MajesTEC-3 study supports teclistamab plus daratumumab SC as potential standard of care
Proof-of-concept phase begins with first patient enrolled
Gene therapy shows sustained benefit for adults with haemophilia B
Novel inhaled ENaC blocker shows promise for treatment of cystic fibrosis
